BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2022 10:06:45 AM | Browse: 392 | Download: 1376
 |
Received |
|
2022-09-02 08:27 |
|
Peer-Review Started |
|
2022-09-02 08:33 |
|
First Decision by Editorial Office Director |
|
2022-10-20 18:37 |
|
Return for Revision |
|
2022-10-20 18:37 |
|
Revised |
|
2022-11-07 12:42 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-12-07 03:23 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-12-07 17:16 |
|
Articles in Press |
|
2022-12-07 17:16 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-12-20 23:59 |
|
Publish the Manuscript Online |
|
2022-12-27 10:06 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
COVID-19 vaccination and liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sotaro Ozaka, Takashi Kobayashi, Kazuhiro Mizukami and Kazunari Murakami |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sotaro Ozaka, MD, PhD, Assistant Professor, Department of Gastroenterology, Faculty of Medicine, Oita University, 1-1 Idaigaoka, Hasama, Yufu 879-5593, Oita, Japan. ozakaso@oita-u.ac.jp |
| Key Words |
COVID-19 vaccine; Liver disease; Side effect; Liver injury; Immune-related hepatitis; Autoimmune hepatitis |
| Core Tip |
Patients with chronic liver disease (CLD), including cirrhosis, are a high-risk group for severe coronavirus disease 2019 (COVID-19). Presently, the results of several clinical trials for measuring the efficacy and safety of the available COVID-19 vaccines in patients with CLD have been reported. Given the increased rates of severity and mortality of COVID-19 in patients with CLD, the importance of aggressive vaccination in the effective management of severe acute respiratory syndrome coronavirus 2 infection should be emphasized. Although liver injury following COVID-19 vaccination has also been reported, it is infrequent and is not a factor in vaccine hesitancy. |
| Publish Date |
2022-12-27 10:06 |
| Citation |
Ozaka S, Kobayashi T, Mizukami K, Murakami K. COVID-19 vaccination and liver disease. World J Gastroenterol 2022; 28(48): 6791-6810 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i48/6791.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i48.6791 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
